BRPI0414869A - compostos e composições como inibidores da proteìna quinase - Google Patents
compostos e composições como inibidores da proteìna quinaseInfo
- Publication number
- BRPI0414869A BRPI0414869A BRPI0414869-0A BRPI0414869A BRPI0414869A BR PI0414869 A BRPI0414869 A BR PI0414869A BR PI0414869 A BRPI0414869 A BR PI0414869A BR PI0414869 A BRPI0414869 A BR PI0414869A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- compositions
- protein kinase
- kinase inhibitors
- raf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMPOSTOS E COMPOSIçõES COMO INIBIDORES DA PROTEìNA QUINASE". A presente invenção refere-se a uma nova classe de compostos, composições farmacêuticas que compreendem tais compostos e processos para a utilização de tais compostos para tratar ou prevenir doenças ou distúrbios associados com a atividade anormal ou desregulada de quinases, particularmente doenças ou distúrbios que envolvem a ativação anormal das quinases Abl BCR-Abl, PDGF-R, Ick, SAPK2<244>, p38, TGF<225>, KDR, c-Kit, b-RAF, c-RAF, FLT1 e FLT4.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50845003P | 2003-10-02 | 2003-10-02 | |
PCT/US2004/032597 WO2005030151A2 (en) | 2003-10-02 | 2004-10-01 | Compounds and compositions as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0414869A true BRPI0414869A (pt) | 2006-11-28 |
Family
ID=34393249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0414869-0A BRPI0414869A (pt) | 2003-10-02 | 2004-10-01 | compostos e composições como inibidores da proteìna quinase |
Country Status (9)
Country | Link |
---|---|
US (2) | US7569593B2 (pt) |
EP (1) | EP1670780A4 (pt) |
JP (1) | JP2007507540A (pt) |
CN (1) | CN100455579C (pt) |
AU (1) | AU2004275888B2 (pt) |
BR (1) | BRPI0414869A (pt) |
CA (1) | CA2540518A1 (pt) |
MX (1) | MXPA06003644A (pt) |
WO (1) | WO2005030151A2 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007533730A (ja) * | 2004-04-20 | 2007-11-22 | アブ サイエンス | 筋炎および筋ジストロフィーを含む炎症性筋疾患を処置するためのc−kit阻害剤の使用法 |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
CA2688487A1 (en) * | 2007-06-15 | 2008-12-24 | Irm Llc | Compounds and compositions as itpkb inhibitors |
SI2300013T1 (en) | 2008-05-21 | 2018-03-30 | Adriad Pharmacaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
WO2010095227A1 (ja) * | 2009-02-19 | 2010-08-26 | 富士通株式会社 | 新規化合物、並びに、結合阻害剤、抗アレルギー剤、抗喘息剤、及び抗炎症剤 |
JP5370472B2 (ja) * | 2009-02-19 | 2013-12-18 | 富士通株式会社 | 新規化合物、並びに、結合阻害剤、抗アレルギー剤、抗喘息剤、及び抗炎症剤 |
EA201391626A1 (ru) | 2011-05-04 | 2014-03-31 | Ариад Фармасьютикалз, Инк. | Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака |
CN103159735B (zh) * | 2011-12-10 | 2015-12-09 | 通化济达医药有限公司 | 取代的咪唑激酶抑制剂 |
JP6469567B2 (ja) | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
CN109476629B (zh) * | 2016-07-22 | 2022-04-15 | 先正达参股股份有限公司 | 脲和硫脲取代的双环衍生物作为杀有害生物剂 |
CN108103186B (zh) * | 2018-02-28 | 2021-07-02 | 固安博健生物技术有限公司 | 诊断类风湿性关节炎和骨关节炎的分子标志物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916891A (en) * | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
WO1995003297A1 (en) | 1993-07-21 | 1995-02-02 | Smithkline Beecham Corporation | Imidazoles for treating cytokine mediated disease |
MX9603202A (es) * | 1994-02-04 | 1997-03-29 | Smithkline Beecham Plc | Procedimiento para epoxidacion de olefinas proquirales y un catalizador para la misma e intermediarios para hacer el catalizador. |
GB2306108A (en) * | 1995-10-13 | 1997-04-30 | Merck & Co Inc | Treatment of Raf-mediated cancers with imidazole derivatives |
EP0889887A4 (en) * | 1996-03-25 | 2003-06-11 | Smithkline Beecham Corp | TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES |
WO1997036587A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | A method of treating cancer |
GB9713726D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
US6207687B1 (en) * | 1998-07-31 | 2001-03-27 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
MXPA02005106A (es) * | 1999-11-22 | 2002-11-07 | Smithkline Beecham Plc | Compuestos novedosos. |
EP1318992B1 (en) * | 2000-09-21 | 2005-07-27 | Smithkline Beecham Plc | Imidazole derivatives as raf kinase inhibitors |
JP4217480B2 (ja) | 2000-11-20 | 2009-02-04 | スミスクライン・ビーチャム・コーポレイション | 新規化合物 |
EP1975620A3 (en) * | 2001-03-02 | 2008-12-24 | GPC Biotech AG | Three hybrid assay system |
-
2004
- 2004-10-01 BR BRPI0414869-0A patent/BRPI0414869A/pt not_active IP Right Cessation
- 2004-10-01 JP JP2006534216A patent/JP2007507540A/ja active Pending
- 2004-10-01 MX MXPA06003644A patent/MXPA06003644A/es unknown
- 2004-10-01 EP EP04809853A patent/EP1670780A4/en not_active Withdrawn
- 2004-10-01 CA CA002540518A patent/CA2540518A1/en not_active Abandoned
- 2004-10-01 CN CNB2004800285104A patent/CN100455579C/zh not_active Expired - Fee Related
- 2004-10-01 AU AU2004275888A patent/AU2004275888B2/en not_active Ceased
- 2004-10-01 US US10/956,880 patent/US7569593B2/en not_active Expired - Fee Related
- 2004-10-01 WO PCT/US2004/032597 patent/WO2005030151A2/en active Search and Examination
-
2009
- 2009-06-25 US US12/492,081 patent/US20090258910A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7569593B2 (en) | 2009-08-04 |
WO2005030151A3 (en) | 2005-09-09 |
AU2004275888B2 (en) | 2008-09-18 |
EP1670780A4 (en) | 2008-12-17 |
AU2004275888A1 (en) | 2005-04-07 |
US20090258910A1 (en) | 2009-10-15 |
JP2007507540A (ja) | 2007-03-29 |
EP1670780A2 (en) | 2006-06-21 |
CN100455579C (zh) | 2009-01-28 |
US20050209285A1 (en) | 2005-09-22 |
WO2005030151A2 (en) | 2005-04-07 |
MXPA06003644A (es) | 2006-06-20 |
CA2540518A1 (en) | 2005-04-07 |
CN1860111A (zh) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0414930A (pt) | compostos e composições como inibidores de proteìnas cinases | |
BRPI0507668A (pt) | compostos e composições como inibidores de proteìna cinase | |
BRPI0409173A (pt) | compostos e composições como inibidores de proteìna quinase | |
BRPI0719797A8 (pt) | Compostos e composições como inibidores de proteína cinase | |
BRPI0415210A (pt) | compostos e composições como inibidores de proteìna cinase | |
BRPI0511978A (pt) | compostos e composições como inibidores de proteìnas quinases | |
PL1896470T3 (pl) | Pochodne pirolopirydynowe jako inhibitory kinazy białkowej | |
MX2008002165A (es) | Compuestos y composiciones como inhibidores de la proteina cinasa. | |
BRPI0512422A (pt) | compostos e composições como inobidores da proteìna quinase | |
BRPI0414869A (pt) | compostos e composições como inibidores da proteìna quinase | |
BRPI0414049A (pt) | compostos e composições como inibidores de proteìna cinase | |
TNSN06053A1 (en) | 6-substituted anilino purines as rtk inhibitors | |
TW200637547A (en) | Compounds and compositions as protein kinase inhibitors | |
UA97816C2 (en) | Compounds modulating c-kit and/or c-fms activity and use thereof | |
BRPI0517015A (pt) | compostos e composições como inibidores de atividade de receptor 1 de canabinóide | |
UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
TW200616632A (en) | Compounds modulating c-kit activity and uses therefor | |
MX2010002005A (es) | Derivados de 2-heteroaril-amino-pirimidina como inhibidores de cinasa. | |
BR0215429A (pt) | Composto de fórmula i e seus usos, métodos de inibição da atividade e método de inibição da ativação de um receptor de monoamina, métodos de tratamento, método de identificação de polimorfismo genético e método de identificação de paciente | |
BR112012004453A8 (pt) | composto inibidor de proteína quinase, sua composição farmacêutica e seu uso | |
BRPI0415467A (pt) | compostos de 2-aminoariloxazol para o tratamento de doenças | |
EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
MX2009011951A (es) | Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
ECSP099353A (es) | Composiciones y métodos para modular los receptores | |
WO2006105516A3 (en) | Compositions and methods for diagnosing and treating neuropsychiatric disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA INT.CL: C07D 401/04, A61P 35/00, A61P 37/00, A61P 25/00 Ipc: C07D 401/04 (2011.01) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |